GIANCANE, GABRIELLA
 Distribuzione geografica
Continente #
EU - Europa 3.751
AS - Asia 482
NA - Nord America 383
Continente sconosciuto - Info sul continente non disponibili 131
SA - Sud America 39
AF - Africa 12
Totale 4.798
Nazione #
IT - Italia 3.665
US - Stati Uniti d'America 353
SG - Singapore 188
CN - Cina 116
VN - Vietnam 82
BD - Bangladesh 40
FR - Francia 34
BR - Brasile 24
HK - Hong Kong 20
DE - Germania 16
CA - Canada 14
GB - Regno Unito 8
IN - India 8
AR - Argentina 5
JP - Giappone 5
ZA - Sudafrica 5
DO - Repubblica Dominicana 4
IQ - Iraq 4
MX - Messico 4
RO - Romania 4
CO - Colombia 3
FI - Finlandia 3
JM - Giamaica 3
NL - Olanda 3
PK - Pakistan 3
RU - Federazione Russa 3
UA - Ucraina 3
VE - Venezuela 3
AM - Armenia 2
AT - Austria 2
EC - Ecuador 2
ID - Indonesia 2
MA - Marocco 2
PH - Filippine 2
TR - Turchia 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SC - Seychelles 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.667
Città #
Genova 1.878
Genoa 1.071
Rapallo 362
Vado Ligure 303
Singapore 94
San Jose 81
Ashburn 32
Lauterbourg 30
New York 24
Beijing 22
Ho Chi Minh City 19
Hong Kong 19
Council Bluffs 16
Hanoi 16
Santa Clara 10
Chicago 8
Haiphong 8
Frankfurt am Main 6
Los Angeles 6
Milan 6
Montreal 6
Bordighera 5
Rome 5
Berlin 4
Buffalo 4
Chennai 4
Da Nang 4
Dallas 4
Houston 4
Orem 4
Tokyo 4
Vedano Olona 4
Biên Hòa 3
Boston 3
Kingston 3
Kyiv 3
Manchester 3
Mexico City 3
Philadelphia 3
Piscataway 3
Princeton 3
Santo Domingo 3
São Paulo 3
Thái Bình 3
Tianjin 3
Wesley Chapel 3
Abingdon 2
Acalanes Ridge 2
Agadir 2
Altoona 2
Amsterdam 2
Belleville 2
Brockton 2
Can Tho 2
Changsha 2
City of London 2
Denver 2
Detroit 2
Fredericksburg 2
Helsinki 2
Indpls 2
Islamabad 2
Johannesburg 2
Leipzig 2
L’Aquila 2
Moscow 2
Naples 2
Nuremberg 2
Orlando 2
Phoenix 2
Pittsburgh 2
Portland 2
Queens 2
Riverside 2
Rosarno 2
San Francisco 2
Shanghai 2
Toronto 2
Washington 2
Addis Ababa 1
Alagoinhas 1
Albuquerque 1
Ancona 1
Antioch 1
Araçoiaba 1
Argenta 1
Arima 1
Arlington 1
Athens 1
Atlanta 1
Baghdad 1
Baltimore 1
Bangkok 1
Banyuwangi 1
Barueri 1
Basingstoke 1
Basra 1
Bengaluru 1
Benito Juarez 1
Blackburn 1
Totale 4.192
Nome #
Juvenile Idiopathic Arthritis: Diagnosis and Treatment 220
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 201
Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry 190
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 186
Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis. 185
Clinical outcome measures in juvenile idiopathic arthritis 181
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases 173
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 168
Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era 165
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever 164
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 163
EULAR recommendations for the management of familial Mediterranean fever 162
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 160
Recent therapeutic advances in juvenile idiopathic arthritis 159
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 158
Temporomandibular joint involvement in juvenile idiopathic arthritis: Reliability and validity of a screening protocol for the rheumatologist 151
Update on the pathogenesis and treatment of juvenile idiopathic arthritis 148
Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. 147
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 135
Primary hypertrophic osteoarthropathy: An update on patient features and treatment 132
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 127
Information technology in paediatric rheumatology 124
Treatment of juvenile idiopathic arthritis: what's new? 124
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 123
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 121
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 113
Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? 113
The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis 105
Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study 104
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 99
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis 99
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis 99
Outcome Scores in Pediatric Rheumatology 56
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 43
Totale 4.798
Categoria #
all - tutte 17.081
article - articoli 16.576
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 14 12 18 32 14 38 15 79 43 51 20 64
2022/2023424 35 40 8 40 84 60 1 34 71 1 45 5
2023/2024243 17 32 4 39 21 18 19 14 16 11 10 42
2024/2025774 32 50 34 60 70 71 78 158 23 42 85 71
2025/20261.249 201 27 50 53 181 94 183 41 89 148 77 105
2026/2027106 106 0 0 0 0 0 0 0 0 0 0 0
Totale 4.798